Achieving body weight loss of 515% can improve cardiometabolic parameters including prediabetes, dyslipidemia, and hypertension [5, 9]
Average 28.7% body weight loss at 68 weeks at the 12 mg dose (about 71.2 lbs / 32.3 kg average loss)
Semaglutide has been marketed for over a decade in diabetes care, and SELECT outcomes data extends beyond five years
Research has linked GLP-1 medications to lower risks of cardiovascular disease, kidney disease, and even some neurodegenerative disorders
If cost is your main issue, Defnet suggests calling your provider to see if there are manufacturer coupons, patient assistance programs, or even other (more affordable) weight loss medications
The duration for which an individual stays on Semaglutide GLP-1 for weight loss may vary depending on various factors, including the individuals overall health, response to the medication, and the recommendation of their healthcare provider